Gland Pharma Limited

₹3,133As of Sun 8 Nov 2026, 12:00 UTC
NSE:GLANDHealthcare
Country India
PE (Fwd) •••
TSR 6Y CAGR 7.34%
Div yield 0.64%
ROE 12.21%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.52
PE TTM 41.84
TSR TTM 63.64%
Mkt cap ₹516.8B
ROIC 14.01%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹3,256
3.92%
(75.69%)
Hold 8|2|10|4|5
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
32.20
32.35
31.60
30.15
19.29%
22.39%
13.64%
4.26%
Revenue₹B
31.47
31.00
32.40
32.52
4.12%
(1.63%)
1.39%
3.60%
Peers (US$5.568B)
Cap (US$)
PE
6.744B
29.36x
5.968B
33.91x
5.236B
35.06x
Capital
TTM
5Y
10Y
Leveragex
0.677
0.055
0.061
EBIT/Intx
1.251
0.187
0.156
Own earn%
(9.95)
3.92
9.35
Sh yield%
15.18
11.59
12.51
Owners
Insiders/Inst%
8.72
65.59
Short interest%
1.35
SBC / revenue%
3.57
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
18–22
$1 testx
−0.1
Incr. ROIC%
3